X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11022) 11022
Publication (1009) 1009
Newspaper Article (326) 326
Newsletter (321) 321
Book Review (215) 215
Book Chapter (69) 69
Magazine Article (17) 17
Conference Proceeding (16) 16
Book / eBook (14) 14
Dissertation (13) 13
Trade Publication Article (13) 13
Reference (2) 2
Data Set (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemotherapy (8476) 8476
humans (7963) 7963
index medicus (7464) 7464
oncology (7269) 7269
cancer (5682) 5682
female (4074) 4074
male (3695) 3695
middle aged (3357) 3357
colorectal cancer (3351) 3351
aged (3244) 3244
metastasis (3097) 3097
antineoplastic combined chemotherapy protocols - therapeutic use (3051) 3051
care and treatment (2869) 2869
adult (2500) 2500
cetuximab (2455) 2455
treatment outcome (2246) 2246
research (2058) 2058
cancer therapies (2023) 2023
colorectal neoplasms - drug therapy (1867) 1867
medicine & public health (1810) 1810
antineoplastic agents - therapeutic use (1684) 1684
tumors (1684) 1684
surgery (1673) 1673
colorectal neoplasms - pathology (1661) 1661
radiotherapy (1606) 1606
survival (1591) 1591
prognosis (1573) 1573
bevacizumab (1525) 1525
health aspects (1500) 1500
1st-line treatment (1474) 1474
fluorouracil (1469) 1469
analysis (1453) 1453
aged, 80 and over (1439) 1439
oxaliplatin (1400) 1400
drug therapy (1363) 1363
disease-free survival (1316) 1316
patients (1313) 1313
clinical trials (1285) 1285
mutation (1257) 1257
neoplasm staging (1204) 1204
growth-factor receptor (1203) 1203
hematology, oncology and palliative medicine (1150) 1150
therapy (1138) 1138
phase-iii trial (1092) 1092
antineoplastic agents (1078) 1078
cisplatin (1066) 1066
antineoplastic combined chemotherapy protocols - adverse effects (1047) 1047
pharmacology & pharmacy (1035) 1035
antimitotic agents (1021) 1021
neoplasm metastasis (1010) 1010
fluorouracil - administration & dosage (1005) 1005
retrospective studies (999) 999
epidermal growth factor (981) 981
leucovorin (964) 964
squamous-cell carcinoma (936) 936
trial (935) 935
irinotecan (931) 931
medical prognosis (928) 928
squamous cell carcinoma (904) 904
phase-ii trial (879) 879
antibodies, monoclonal, humanized (864) 864
camptothecin - analogs & derivatives (853) 853
animals (851) 851
open-label (849) 849
combined modality therapy (836) 836
survival rate (832) 832
radiation therapy (831) 831
antineoplastic combined chemotherapy protocols - administration & dosage (823) 823
studies (815) 815
combination (806) 806
cancer research (801) 801
carcinoma (798) 798
patient outcomes (798) 798
development and progression (785) 785
survival analysis (783) 783
lung neoplasms - drug therapy (762) 762
randomized-trial (754) 754
genetic aspects (752) 752
lung cancer (742) 742
medical research (734) 734
antibodies, monoclonal - therapeutic use (733) 733
metastases (733) 733
colorectal neoplasms - genetics (731) 731
head and neck cancer (726) 726
phase-ii (716) 716
receptor, epidermal growth factor - antagonists & inhibitors (716) 716
cancer patients (712) 712
liver neoplasms - secondary (701) 701
oncology, experimental (700) 700
antibodies, monoclonal - administration & dosage (693) 693
deoxycytidine - analogs & derivatives (688) 688
organoplatinum compounds - administration & dosage (670) 670
metastatic colorectal-cancer (668) 668
expression (656) 656
capecitabine (655) 655
carcinoma, non-small-cell lung - drug therapy (646) 646
camptothecin - administration & dosage (644) 644
chemoradiotherapy (644) 644
cell lung-cancer (618) 618
medicine (618) 618
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Online Resources - Online (2) 2
Credit Valley Hospital - Reserve desk (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Pharmacy (1) 1
Providence Healthcare - Reference (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Stacks (1) 1
Trillium Health Centre - Reserve desk (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11534) 11534
German (115) 115
French (91) 91
Japanese (32) 32
Chinese (5) 5
Korean (5) 5
Spanish (5) 5
Polish (4) 4
Arabic (3) 3
Latvian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2008, Volume 359, Issue 11, pp. 1116 - 1127
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2004, Volume 351, Issue 4, pp. 337 - 345
In this randomized trial, cetuximab, a monoclonal antibody against the epidermal growth factor receptor, was given alone or in combination with irinotecan to... 
CELL LUNG-CANCER | GROWTH-FACTOR RECEPTOR | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | MULTICENTER RANDOMIZED-TRIAL | PHASE-II TRIAL | TYROSINE KINASE | MONOCLONAL-ANTIBODY | ANTITUMOR-ACTIVITY | FLUOROURACIL-LEUCOVORIN | RESISTANT CHINESE-HAMSTER | Single-Blind Method | Adenocarcinoma - pathology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Topoisomerase I Inhibitors | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antibodies, Monoclonal, Humanized | Neoplasm Metastasis | Receptor, Epidermal Growth Factor - metabolism | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Female | Cetuximab | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Dosage and administration | Drug therapy, Combination | Research | Drug therapy | Colorectal cancer | Nuclear magnetic resonance--NMR | Epidermal growth factor
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 21 - 28
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1065 - 1075
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 8, pp. 1050 - 1058
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9674, pp. 1525 - 1531
Summary Background Use of cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor (EGFR), has the potential to increase survival in... 
Internal Medicine | GROWTH-FACTOR RECEPTOR | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | THERAPY | CISPLATIN | COMBINATION | GEMCITABINE | ERLOTINIB | PACLITAXEL | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptor, Epidermal Growth Factor - drug effects | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Young Adult | Antibodies, Monoclonal, Humanized | Vinblastine - analogs & derivatives | Aged, 80 and over | Adult | Female | Cetuximab | Carcinoma, Non-Small-Cell Lung - pathology | Proportional Hazards Models | Survival Rate | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Carcinoma, Non-Small-Cell Lung - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Chemotherapy | Research | Comparative analysis | Lung cancer, Non-small cell | Drug therapy | Health aspects | Cancer | Drugs | Studies | Data analysis | Lung cancer | Acne | Monoclonal antibodies | Clinical medicine | Kinases | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article